Matrix metalloproteinases in COPD

Churg A., Zhou S., Wright J.L.

Source: Eur Respir J 2012; 39: 197-209
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Churg A., Zhou S., Wright J.L.. Matrix metalloproteinases in COPD. Eur Respir J 2012; 39: 197-209

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Source: Eur Respir J 2008; 32: 644-650
Year: 2008



Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005



Extracellular matrix composition in COPD
Source: Eur Respir J 2012; 40: 1362-1373
Year: 2012



Matrix metalloproteinases and their inhibitors in pulmonary hypertension},
Source: Eur Respir J 2012; 40: 766-782
Year: 2012



Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001

Interaction of matrix metalloproteinases with pulmonary pollutants
Source: Eur Respir J 2012; 39: 1021-1032
Year: 2012



Expression of matrix metalloproteinases and TIMP inhibitors in circulation/lung in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012


Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Matrix metalloproteinases in pulmonary fibrosis
Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis
Year: 2013


Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair
Source: Eur Respir J 2011; 38: 959-970
Year: 2011



Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF
Source: Eur Respir J 2002; 20: 1220-1227
Year: 2002



Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007



Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007


Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 834-842
Year: 2005



Local matrix metalloprotease-8 and neutrophils in the airways of tobacco smokers with or without chronic bronchitis
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003

Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Metalloproteinases in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1461-1467
Year: 2011